This Week: short on funding, long on research and analysis - ESW #363

Only one funding announcement this week, so we dive deep into Thoma Bravo's past and present portfolio. They recently announced a sale of Venafi to Cyberark and no one is quite sure how much of a hand they had in the LogRhythm/Exabeam merger, and whether or not they sold their stake in the process.

We also have a crazy stat Ross Haleliuk spotted in Bessemer's analysis: "13 out of 14 cybersecurity companies acquired in the past year for over $100M were from Israel". Is this an anomaly? Does it just mean that Israel wasn't shy about selling when the market was down? We discuss.

A number of new product announcements continue to trickle out post-RSA.

We'll also discuss Sam Altman and OpenAI's decision to use Scarlett Johansson's voice against her will and what it could mean for deepfakes, advanced social engineering techniques, and general big tech sliminess.

Do you know what a "product glorifier" is? How about a glowstacker? You will if you check out the second-to-last story in the show notes!

Show Notes: https://securityweekly.com/esw-363